Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000002

Chief Commercial Officer sold 2,804 shares at $32.18 ($90,233)

  • Chief Commercial Officer acquired 8,476 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Milanova Tsveta Chief Commercial Officer 2025-01-03 Option exercise 10b5-1 +8,476 21,710 D
Milanova Tsveta Chief Commercial Officer 2025-01-06 Sale 10b5-1 −2,804 $32.18 $90,233 18,906 D
Derivatives
Milanova Tsveta Chief Commercial Officer 2025-01-03 Option exercise · Restricted stock units 10b5-1 −8,476 8,475 D
Open-market sales · 2,804 sh · avg $32.18 · $90,233
Loading xslF345X05/wk-form4_1736287498.xml…